B Cell Abnormalities in Systemic Lupus Erythematosus

Overview

Journal Arthritis Res Ther

Publisher Biomed Central

Specialty Rheumatology

Date 2004 Jun 8

PMID 15180894

Citations 49

Authors

Amrie C Grammer

Peter E Lipsky

Affiliations

Soon will be listed here.

Abstract

Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by the differentiation of short- and long-lived immunoglobulin secreting plasma cells that secrete pathogenic autoantibodies. Ectopic germinal centers and plasma cells secreting autoantibodies have been observed in lupus nephritis kidneys. Candidate genetic susceptibility loci for SLE include genes that affect differentiation and survival of plasma cells, such as those that influence activation, proliferation, cytokine and chemokine secretion/responsiveness, and apoptosis of the T and B cells that are involved in humoral immunity generated in germinal centers, as well as genes that are involved in presentation and clearance of apoptotic material and autoantigens by antigen presenting cells and other phagocytes. Emerging data have demonstrated that B lymphocytes are active participants in humoral immune responses that lead to T-dependent and T-independent differentiation of immunoglobulin-secreting plasma cells by homotypic CD154-CD40 interactions as well as continued stimulation by B cell activating factor through B cell maturation antigen, B cell activating factor receptor and transmembrane activater.

Citing Articles

Interferon activation in bone marrow long-lived plasma cells in systemic lupus erythematosus.

Alzamareh D, Meednu N, Nandedkar-Kulkarni N, Krenitsky D, Barnard J, Yasaka K Front Immunol. 2025; 15:1499551.

PMID: 39867907 PMC: 11757124. DOI: 10.3389/fimmu.2024.1499551.

Aberrant zonal recycling of germinal center B cells impairs appropriate selection in lupus.

Sanchez G, Hirsch E, VanValkenburg A, Mayer D, Gbedande K, Francis R Cell Rep. 2024; 43(11):114978.

PMID: 39527476 PMC: 11682828. DOI: 10.1016/j.celrep.2024.114978.

Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases.

Gong X, He S, Cai P Front Immunol. 2024; 15:1435525.

PMID: 39165359 PMC: 11333224. DOI: 10.3389/fimmu.2024.1435525.

Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.

Bell C, Wu B, Huang S, Rubin B, Averell C, Chastek B BMC Health Serv Res. 2024; 24(1):691.

PMID: 38822336 PMC: 11143616. DOI: 10.1186/s12913-024-11060-6.

Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density.

Shevchuk S, Marynych L, Malovana T, Denyshchych L Lupus Sci Med. 2023; 10(2).

PMID: 37558268 PMC: 10414063. DOI: 10.1136/lupus-2023-000968.

References

Jelinek D, Lipsky P . The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J Immunol. 1983; 130(6):2597-604. View

McCarty G, Rice J, Bembe M, Pisetsky D . Independent expression of autoantibodies in systemic lupus erythematosus. J Rheumatol. 1982; 9(5):691-5. View

Vernino L, McAnally L, Ramberg J, Lipsky P . Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells. J Immunol. 1992; 148(2):404-10. View

Cooke M, Heath A, Shokat K, Zeng Y, Finkelman F, Linsley P . Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med. 1994; 179(2):425-38. PMC: 2191355. DOI: 10.1084/jem.179.2.425. View

Eris J, Basten A, Brink R, Doherty K, Kehry M, Hodgkin P . Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci U S A. 1994; 91(10):4392-6. PMC: 43791. DOI: 10.1073/pnas.91.10.4392. View

Mohan C, Shi Y, Laman J, Datta S . Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol. 1995; 154(3):1470-80. View

Grammer A, Bergman M, Miura Y, Fujita K, Davis L, Lipsky P . The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol. 1995; 154(10):4996-5010. View

Han S, Hathcock K, Zheng B, Kepler T, Hodes R, Kelsoe G . Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol. 1995; 155(2):556-67. View

Lentz V, Cancro M, Nashold F, Hayes C . Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J Immunol. 1996; 157(2):598-606. View

10.

Jacobson B, Rothstein T, Marshak-Rothstein A . Unique site of IgG2a and rheumatoid factor production in MRL/lpr mice. Immunol Rev. 1997; 156:103-10. DOI: 10.1111/j.1600-065x.1997.tb00962.x. View

11.

Mandik-Nayak L, Bui A, Noorchashm H, Eaton A, Erikson J . Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med. 1997; 186(8):1257-67. PMC: 2199093. DOI: 10.1084/jem.186.8.1257. View

12.

Devi B, Van Noordin S, Krausz T, Davies K . Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun. 1998; 11(5):471-5. DOI: 10.1006/jaut.1998.0213. View

13.

Moser K, Neas B, Salmon J, Yu H, Gray-McGuire C, Asundi N . Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A. 1998; 95(25):14869-74. PMC: 24542. DOI: 10.1073/pnas.95.25.14869. View

14.

Grammer A, McFarland R, Heaney J, Darnell B, Lipsky P . Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J Immunol. 1999; 163(8):4150-9. View

15.

McCune W, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox D . Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med. 1988; 318(22):1423-31. DOI: 10.1056/NEJM198806023182203. View

16.

Feuerstein N, Chen F, Madaio M, Maldonado M, Eisenberg R . Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol. 1999; 163(10):5287-97. View

17.

Mackay F, Woodcock S, Lawton P, Ambrose C, Baetscher M, Schneider P . Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999; 190(11):1697-710. PMC: 2195729. DOI: 10.1084/jem.190.11.1697. View

18.

Khare S, Sarosi I, Xia X, McCabe S, Miner K, Solovyev I . Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A. 2000; 97(7):3370-5. PMC: 16246. DOI: 10.1073/pnas.97.7.3370. View

19.

Gross J, Johnston J, Mudri S, Enselman R, Dillon S, Madden K . TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000; 404(6781):995-9. DOI: 10.1038/35010115. View

20.

Do R, Hatada E, Lee H, Tourigny M, Hilbert D, Chen-Kiang S . Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000; 192(7):953-64. PMC: 2193312. DOI: 10.1084/jem.192.7.953. View